Protein tyrosine phosphatase non-receptor II: A possible biomarker of poor prognosis and mediator of immune evasion in hepatocellular carcinoma

doi:10.4251/wjgo.v16.i9.3913

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-7) series.

Item

Count

PDF

HTML

Figures (1-5)

Tables (1-7)

Sum=5

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=3

Publishing Process of This Article

Item

Count

Browse

Download

Sum=0

Sep 15, 2024 (publication date) through Sep 9, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical and Translational Research

World J Gastrointest Oncol. Sep 15, 2024; 16(9): 3913-3931
Published online Sep 15, 2024. doi: 10.4251/wjgo.v16.i9.3913

Table 2 Protein tyrosine phosphatase non-receptor 2 expression in hepatocellular carcinoma tumor tissues and paracancerous tissues

Tumor tissue	Paracancer tissue		Total	χ²	P value
Tumor tissue	High expression	Low expression	Total	χ²	P value
High expression	16	69	85	12.163	< 0.001
Low expression	20	21	41	12.163
Total	36	90

Citation: Li HY, Jing YM, Shen X, Tang MY, Shen HH, Li XW, Wang ZS, Su F. Protein tyrosine phosphatase non-receptor II: A possible biomarker of poor prognosis and mediator of immune evasion in hepatocellular carcinoma. World J Gastrointest Oncol 2024; 16(9): 3913-3931
URL: https://www.wjgnet.com/1948-5204/full/v16/i9/3913.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i9.3913